WVE - Wave Life Sciences falls sharply on pricing $100M secondary offering
2023-12-07 07:16:38 ET
More on Wave Life Sciences
- Wave Life Sciences Ltd. (WVE) Q3 2023 Earnings Call Transcript
- Wave Life Sciences: Excellent Early Data, Major Collaborations, Needs Cash
- Wave Life Sciences proposes public offering of ordinary shares and pre-funded warrants
- Wave Life Sciences GAAP EPS of $0.07 beats by $0.25, revenue of $49.2M beats by $25.77M
- Seeking Alpha’s Quant Rating on Wave Life Sciences
For further details see:
Wave Life Sciences falls sharply on pricing $100M secondary offering